AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & DrugsHouse : Aurobindo
BSE601.8514.7 (+2.5 %)
PREV CLOSE ( ) 587.15
OPEN PRICE ( ) 581.00
BID PRICE (QTY) 601.85 (204)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 351051
TODAY'S LOW / HIGH ( )581.00 611.75
52 WK LOW / HIGH ( )504 808.95
NSE601.9015.05 (+2.56 %)
PREV CLOSE( ) 586.85
OPEN PRICE ( ) 589.00
BID PRICE (QTY) 601.90 (53)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5799249
TODAY'S LOW / HIGH( ) 588.05 612.00
52 WK LOW / HIGH ( )503.05 809.45
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-12 1986
Management Info
K Ragunathan - Chairman N Govindarajan - Managing Director
Registered Office

Address Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone +91-040-66725000

Email info@aurobindo.com

Website www.aurobindo.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
08Feb Aurobindo Pharma fixes record date for
Aurobindo Pharma has informed that the Company has fixed February 21, 20..
27Dec Aurobindo Pharma gets USFDA’s nod for
Aurobindo Pharma has received final approval from the US Food & Drug..
27Dec Aurobindo Pharma gets USFDA’s nod for
Aurobindo Pharma has received final approval from the US Food & Drug..
27Dec Aurobindo Pharma surges on getting USF
Aurobindo Pharma is currently trading at Rs. 696.85, up by 12.90 points..
18Dec Clarification sought from Aurobindo Ph
The Exchange has sought clarification from Aurobindo Pharma on December..
Financials
Rs. in Millions
QTR Dec 17 ANNUAL 17
Net Profit4443.217067.6
Gross Profit 5946 21785.7
Operating Profit 6980.925099
Net Sales 26862.897812.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr. Reddys Lab (BSE)
 2169.25 (2.26%)
M.Cap (Rs. in Cr)35986.45
Merck (BSE)
 1486.60 (2.96%)
M.Cap (Rs. in Cr)2467.66
Abbott India (BSE)
 5788.40 (0.72%)
M.Cap (Rs. in Cr)12299.95
Zandu Realty (BSE)
 1993.80 (1.95%)
M.Cap (Rs. in Cr)160.78
Piramal Enterprises (BSE)
 2622.05 (1.31%)
M.Cap (Rs. in Cr)47275.73
Shareholding Pattern
PROMOTERS 51.87%
MUTUAL FUNDS/UTI 14.97%
NON-INSTITUTION 13.67%
FI/BANKS/INSURANCE 0.58%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.